Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ultrastructural study of Chlamydia pneumoniae in a continuous-infection model.

Literature DB >> 11574601

Ultrastructural study of Chlamydia pneumoniae in a continuous-infection model.

A Kutlin¹, C Flegg, D Stenzel, T Reznik, P M Roblin, S Mathews, P Timms, M R Hammerschlag.

Abstract

We have established an in vitro model of long-term continuous Chlamydia pneumoniae infection in HEp-2 cells. Using transmission electron microscopy, we demonstrated the presence of spontaneous abnormal chlamydial inclusions similar in appearance to the persistent chlamydial forms induced in vitro by treatment with cytokines or antibiotics or by nutrient deprivation.

Entities: Disease

Mesh：

Year: 2001 PMID： 11574601 PMCID： PMC88417 DOI： 10.1128/JCM.39.10.3721-3723.2001

Source DB: PubMed Journal: J Clin Microbiol ISSN： 0095-1137 Impact factor: 5.948

19 in total

1. Effect of antiserum and antibiotics on persistent infection of HeLa cells with meningopneumonitis virus.

Authors: G J GALASSO; G P MANIRE
Journal: J Immunol Date: 1961-04 Impact factor: 5.422

2. Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae.

Authors: P M Roblin; W Dumornay; M R Hammerschlag
Journal: J Clin Microbiol Date: 1992-08 Impact factor: 5.948

3. Persistent infection with Chlamydia pneumoniae following acute respiratory illness.

Authors: M R Hammerschlag; K Chirgwin; P M Roblin; M Gelling; W Dumornay; L Mandel; P Smith; J Schachter
Journal: Clin Infect Dis Date: 1992-01 Impact factor: 9.079

4. Ultrastructural analysis of the effect of trimethoprim and sulphamethoxazole on the development of Chlamydia trachomatis in cell culture.

Authors: M R Hammerschlag; J C Vuletin
Journal: J Antimicrob Chemother Date: 1985-02 Impact factor: 5.790

5. Chlamydial development is adversely affected by minor changes in amino acid supply, blood plasma amino acid levels, and glucose deprivation.

Authors: A Harper; C I Pogson; M L Jones; J H Pearce
Journal: Infect Immun Date: 2000-03 Impact factor: 3.441

6. Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro.

Authors: U Dreses-Werringloer; I Padubrin; B Jürgens-Saathoff; A P Hudson; H Zeidler; L Köhler
Journal: Antimicrob Agents Chemother Date: 2000-12 Impact factor: 5.191

7. Ultrastructural effect of penicillin and cycloheximide on Chlamydia trachomatis strain HAR-13.

Authors: R B Clark; P F Schatzki; H P Dalton
Journal: Med Microbiol Immunol Date: 1982 Impact factor: 3.402

8. Activity of trimethoprim-sulfamethoxazole against Chlamydia trachomatis in vitro.

Authors: M R Hammerschlag
Journal: Rev Infect Dis Date: 1982 Mar-Apr

9. Ultrastructural analysis of the effects of erythromycin on the morphology and developmental cycle of Chlamydia trachomatis HAR-13.

Authors: R B Clark; P F Schatzki; H P Dalton
Journal: Arch Microbiol Date: 1982-12-03 Impact factor: 2.552

10. Electron microscopic observations on the effects of penicillin on the morphology of Chlamydia psittaci.

Authors: A Matsumoto; G P Manire
Journal: J Bacteriol Date: 1970-01 Impact factor: 3.490

12 in total

Review 1. Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies.

Authors: Jens Boman; Margaret R Hammerschlag
Journal: Clin Microbiol Rev Date: 2002-01 Impact factor: 26.132

2. Chlamydia pneumoniae resists antibiotics in lymphocytes.

Authors: Hiroyuki Yamaguchi; Herman Friedman; Mayumi Yamamoto; Keigo Yasuda; Yoshimasa Yamamoto
Journal: Antimicrob Agents Chemother Date: 2003-06 Impact factor: 5.191

3. Chlamydia pneumoniae activates epithelial cell proliferation via NF-kappaB and the glucocorticoid receptor.

Authors: Mikael M Cornelsen Gencay; Michael Tamm; Allan Glanville; André P Perruchoud; Michael Roth
Journal: Infect Immun Date: 2003-10 Impact factor: 3.441

4. Genetic and culture-based approaches for detecting macrolide resistance in Chlamydia pneumoniae.

Authors: Paul F Riska; Andrei Kutlin; Patrick Ajiboye; Arnold Cua; Patricia M Roblin; Margaret R Hammerschlag
Journal: Antimicrob Agents Chemother Date: 2004-09 Impact factor: 5.191

Review 5. Chlamydial persistence: beyond the biphasic paradigm.

Authors: Richard J Hogan; Sarah A Mathews; Sanghamitra Mukhopadhyay; James T Summersgill; Peter Timms
Journal: Infect Immun Date: 2004-04 Impact factor: 3.441

6. Berberine inhibits HEp-2 cell invasion induced by Chlamydophila pneumoniae infection.

Authors: Li Jun Zhang; Li Jun Zhang; Wei Quan; Bei Bei Wang; Bing Ling Shen; Teng Teng Zhang; Yi Kang
Journal: J Microbiol Date: 2011-11-09 Impact factor: 3.422

7. Comparison of eleven commercial tests for Chlamydia pneumoniae-specific immunoglobulin G in asymptomatic healthy individuals.

Authors: Corinna Hermann; Kathrin Graf; Annemarie Groh; Eberhard Straube; Thomas Hartung
Journal: J Clin Microbiol Date: 2002-05 Impact factor: 5.948

8. Effect of prolonged treatment with azithromycin, clarithromycin, or levofloxacin on Chlamydia pneumoniae in a continuous-infection Model.

Authors: Andrei Kutlin; Patricia M Roblin; Margaret R Hammerschlag
Journal: Antimicrob Agents Chemother Date: 2002-02 Impact factor: 5.191

9. Amalgamation of Chlamydia pneumoniae inclusions with lipid droplets in foam cells in human atherosclerotic plaque.

Authors: Yuri V Bobryshev; Murray C Killingsworth; Dihn Tran; Reginald Lord
Journal: Virchows Arch Date: 2008-06-06 Impact factor: 4.064

10. Comparison of quantitative and semiquantitative enzyme-linked immunosorbent assays for immunoglobulin G against Chlamydophila pneumoniae to a microimmunofluorescence test for use with patients with respiratory tract infections.

Authors: Corinna Hermann; Katja Gueinzius; Albrecht Oehme; Sonja Von Aulock; Eberhard Straube; Thomas Hartung
Journal: J Clin Microbiol Date: 2004-06 Impact factor: 5.948